In Minerva Surgical v. Hologic, the U.S. Supreme Court limited the scope of the patent law concept of assignor estoppel in several key respects. Despite those limitations, assignor estoppel may remain important in certain industries, such as life and physical science start-up companies that develop and commercialize the work of academic-inventors.